IP Library › Assignment 027545/0079
Patent Assignment
Reel/Frame 027545/0079

Assignment of Assignor's Interest

Recorded: 2012-01-10 Pages: 15
Assignor
NUTRITION 21, INC.
Executed: 2011-11-22
Assignee
N21 ACQUISITION HOLDING, LLC
4 MANHATTANVILLE ROAD, PURCHASE, NEW YORK, 10577
Covered Properties (26)
Method for Promoting Weight and Fat Loss
Patent: 5,914,326 →
Application: 08/908,820 →
Chromium Nicotinate Compositions and Uses Thereof
Patent: 5,905,075 →
Application: 09/143,256 →
Chromium Picolinate Compositions and Uses Thereof
Patent: 5,948,772 →
Application: 09/144,026 →
Enteric-Coated Chromium Picolinate Compositions and Uses Thereof
Patent: 6,093,711 →
Application: 09/228,701 →
Enteric-Coated Chromium Polynicotinate Compositions and Uses Thereof
Patent: 6,100,250 →
Application: 09/229,463 →
Chromium Polynicotinate Compositions and Uses Thereof
Patent: 5,980,905 →
Application: 09/291,560 →
Chromium Picolinate Compositions and Uses Thereof
Patent: 6,143,301 →
Application: 09/291,561 →
Chromium Polynicotinate Compositions
Patent: 6,100,251 →
Application: 09/480,473 →
Chromium Polynicotinate Compositions and Uses Thereof for Absorption of Essential Metals
Patent: 6,323,192 →
Application: 09/634,664 →
Chromium Picolinate Compositions and Uses Thereof
Patent: 6,432,942 →
Application: 09/849,865 →
Publication: US 2001/0036490
Methods and Compositions for the Treatment of Diabetes, the Reduction of Body Fat, Improvement of Insulin Sensitivity, Reduction of Hyperglycemia, and Reduction of Hypercholesterolemia with Chromium Complexes, Conjugated Fatty Acids, and/or Conjugated Fatty Alcohol
Patent: 6,809,115 →
Application: 09/957,876 →
Publication: US 2002/0081315
Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia
Application: 10/090,038 →
Publication: US 2002/0197331
Chromium Picolinate Compositions and Uses Threof
Patent: 6,713,469 →
Application: 10/207,748 →
Publication: US 2002/0197340
Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols
Application: 10/319,328 →
Publication: US 2003/0091654
Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
Application: 10/509,487 →
Publication: US 2005/0214384
Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia
Application: 11/136,794 →
Publication: US 2005/0214385
Arginine Silicate Inositol Complex and Use Thereof
Patent: 7,576,132 →
Application: 11/146,620 →
Publication: US 2005/0234019
Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols
Application: 11/435,120 →
Publication: US 2006/0204517
Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols
Application: 11/435,125 →
Publication: US 2006/0204518
Methods and Compositions for the Sustained Release of Chromium
Patent: 8,062,677 →
Application: 12/340,257 →
Publication: US 2009/0155384
Use of Chromium Histidinate for Treatment of Cardiometabolic Disorders
Application: 12/512,430 →
Publication: US 2010/0009015
Chromium Complexes for Improvement of Memory and Cognitive Function
Application: 12/652,282 →
Publication: US 2010/0178362
Methods and Compositions for the Sustained Release of Chromium
Patent: 9,119,835 →
Application: 13/300,059 →
Publication: US 2012/0128794
Sustained Delivery of an Active Agent Using an Implantable System
Patent: 8,535,701 →
Application: 13/645,124 →
Publication: US 2013/0035669
Chromium Complexes as Enhancers of Brain Glucose Transporters
Application: 61/222,255 →
Methods and Compositions for the Treatment and Prevention of Hypoglycemia and Related Disorders
Application: 61/448,134 →
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Jan 18, 2002
From: AMBI INC.
To: NUTRITION 21, INC.
Reel/Frame 012463/0552 →
Assignment of Assignor's Interest Feb 1, 2002
From: KATZ, DAVID P.; KOMOROWSKI, JAMES R.; GREENBERG, DANIELLE
To: NUTRITION 21, INC.
Reel/Frame 012519/0006 →
Assignment of Assignor's Interest Jun 16, 2005
From: GUSTIN, JOHN
To: PHOENICIAN RESEARCH FOUNDATION
Reel/Frame 016700/0108 →
Assignment of Assignor's Interest Sep 13, 2005
From: JUTURU, VIJAYA; KOMOROWSKI, JAMES R.; MONTGOMERY, GAIL
To: NUTRITION 21, INC.
Reel/Frame 016790/0173 →
Assignment of Assignor's Interest Mar 3, 2009
From: KOMOROWSKI, JAMES R.
To: NUTRITION 21, INC.
Reel/Frame 022340/0359 →
Assignment of Assignor's Interest Sep 25, 2009
From: JUTURU, VIJAYA; KOMOROWSKI, JAMES
To: NUTRITION 21, INC.
Reel/Frame 023296/0143 →
Assignment of Assignor's Interest Apr 14, 2010
From: KOMOROWSKI, JAMES R.; JUTURU, VIJAYA
To: NUTRITION 21, INC.
Reel/Frame 024235/0145 →
Change of Name Jan 10, 2012
From: AMBI INC.
To: NUTRITION 21, INC.
Reel/Frame 027545/0051 →
Change of Name Jun 14, 2012
From: N21 ACQUISITION HOLDING, LLC
To: JDS THERAPEUTICS, LLC
Reel/Frame 028603/0993 →
Assignment of Assignor's Interest Dec 7, 2012
From: DE LA HARPE, JON; PRICE, FREDRIC D.; CHAKRIN, LAWRENCE W.; KOMOROWSKI, JAMES R.
To: AMBI, INC.
Reel/Frame 029424/0707 →
Assignment of Assignor's Interest Dec 7, 2012
From: DE LA HARPE, JON; PRICE, FREDRIC D.; CHAKRIN, LAWRENCE W.; KOMOROWSKI, JAMES R.
To: AMBI, INC.
Reel/Frame 029424/0718 →
Change of Name Dec 7, 2012
From: N21 ACQUISITION HOLDING, LLC
To: JDS THERAPEUTICS, LLC
Reel/Frame 029428/0208 →
Change of Name Dec 7, 2012
From: N21 ACQUISITION HOLDING, LLC
To: JDS THERAPEUTICS, LLC
Reel/Frame 029428/0330 →
Assignment of Assignor's Interest Feb 5, 2014
From: JDS THERAPEUTICS, LLC
To: NUTRITION 21, LLC
Reel/Frame 032143/0720 →
Change of Name Feb 3, 2017
From: N21 ACQUISITION HOLDING, LLC
To: JDS THERAPEUTICS, LLC
Reel/Frame 041627/0208 →
Change of Name Feb 3, 2017
From: N21 ACQUISITION HOLDING, LLC
To: JDS THERAPEUTICS, LLC
Reel/Frame 041627/0206 →
Change of Name Feb 3, 2017
From: N21 ACQUISITION HOLDING, LLC
To: JDS THERAPEUTICS, LLC
Reel/Frame 041627/0199 →
Assignment of Assignor's Interest Feb 28, 2017
From: NUTRITION 21, LLC
To: JDS THERAPEUTICS, LLC
Reel/Frame 041399/0516 →
Assignment of Assignor's Interest Feb 28, 2017
From: NUTRITION 21, LLC
To: JDS THERAPEUTICS, LLC
Reel/Frame 041399/0709 →
Change of Name Oct 25, 2018
From: N21 ACQUISITION HOLDING, LLC
To: JDS THERAPEUTICS, LLC
Reel/Frame 047724/0357 →
Assignment of Assignor's Interest Dec 4, 2018
From: JDS THERAPEUTICS, LLC
To: NUTRITION 21, LLC
Reel/Frame 047666/0467 →
Assignment of Assignor's Interest Jul 21, 2021
From: JDS THERAPEUTICS, LLC
To: NUTRITION 21, LLC
Reel/Frame 056933/0653 →
Assignment of Assignor's Interest Jul 21, 2021
From: KOMOROWSKI, JAMES R.
To: NUTRITION 21, INC.
Reel/Frame 056932/0166 →
Security Interest Nov 9, 2021
From: NUTRITION 21, LLC
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 058060/0535 →